U.S. markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
277.96+8.76 (+3.25%)
At close: 1:03PM EST

277.96 0.00 (0.00%)
After hours: 2:11PM EST

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-0645
United States
610 594 2900
http://www.westpharma.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees8,200

Key Executives

NameTitlePayExercisedYear Born
Mr. Eric M. GreenPres, CEO & Director2.28MN/A1970
Mr. Bernard J. BirkettSr. VP & CFO1.18MN/A1969
Mr. David A. MontecalvoSr. VP and Chief Operations & Supply Chain Officer801.65kN/A1965
Mr. George Lloyd MillerSr. VP, Gen. Counsel & Corp. Sec.835.13kN/A1955
Mr. Silji AbrahamChief Digital & Transformation Officer and Sr. VP796.49kN/A1972
Mr. Chad R. WintersVP, Chief Accounting Officer, Principal Accounting Officer & Corp. ControllerN/AN/A1978
Mr. Eric ResnickCTO & VPN/AN/A1964
Dr. Quintin J. Lai C.F.A., Ph.D.VP of Corp. Devel., Strategy & Investor RelationsN/AN/A1967
Michele PelkowskiVP of Global CommunicationsN/AN/AN/A
Ms. Annette F. FavoriteChief HR Officer & Sr. VPN/AN/A1965
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.

Corporate Governance

West Pharmaceutical Services, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 7. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.